- Home
- SYTA vs KTTA Comparison
SYTA vs KTTA Comparison
Compare SYTA & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- KTTA
- Stock Information
- Founded
- SYTA N/A
- KTTA 2020
- Country
- SYTA Canada
- KTTA United States
- Employees
- SYTA N/A
- KTTA N/A
- Industry
- SYTA Telecommunications Equipment
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- SYTA Telecommunications
- KTTA Health Care
- Exchange
- SYTA Nasdaq
- KTTA Nasdaq
- Market Cap
- SYTA 3.1M
- KTTA 2.6M
- IPO Year
- SYTA 2020
- KTTA 2021
- Fundamental
- Price
- SYTA $3.23
- KTTA $1.30
- Analyst Decision
- SYTA
- KTTA
- Analyst Count
- SYTA 0
- KTTA 0
- Target Price
- SYTA N/A
- KTTA N/A
- AVG Volume (30 Days)
- SYTA 240.3K
- KTTA 3.3M
- Earning Date
- SYTA 04-07-2025
- KTTA 03-28-2025
- Dividend Yield
- SYTA N/A
- KTTA N/A
- EPS Growth
- SYTA N/A
- KTTA N/A
- EPS
- SYTA N/A
- KTTA N/A
- Revenue
- SYTA $11,988,979.00
- KTTA N/A
- Revenue This Year
- SYTA $75.92
- KTTA N/A
- Revenue Next Year
- SYTA $19.72
- KTTA N/A
- P/E Ratio
- SYTA N/A
- KTTA N/A
- Revenue Growth
- SYTA 41.59
- KTTA N/A
- 52 Week Low
- SYTA $3.04
- KTTA $1.25
- 52 Week High
- SYTA $885.60
- KTTA $9.25
- Technical
- Relative Strength Index (RSI)
- SYTA 30.99
- KTTA 30.34
- Support Level
- SYTA $3.04
- KTTA $1.32
- Resistance Level
- SYTA $5.40
- KTTA $1.38
- Average True Range (ATR)
- SYTA 0.49
- KTTA 0.26
- MACD
- SYTA -0.06
- KTTA -0.05
- Stochastic Oscillator
- SYTA 8.05
- KTTA 1.92
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.